risks with glp 1 GI Adverse Effects of Glucagon-Like Peptide-1 Receptor Agonists The expanding role of GLP-1
Description
Major players like Novo Nordisk, Eli Lilly, and AstraZeneca are making strategic investments
This system is heavily mediated by dopamine
and 2022YFC2703105 to H.E.X.)
Obesity and type 2 diabetes (T2D) are themselves associated with higher rates of thyroid dysfunction and altered autoimmunity, underscoring the convergence of metabolic and endocrine pathways [5,6]
Glucagon-Like Peptide-1 Receptor Agonists for Non-Alcoholic Fatty Liver Disease in Type 2 Diabetes: A Meta-Analysis
